lifestyle.cosmeticsurgeryinsider.com

Author: BD – BECTON DICKINSON/ INVESTOR RELATIONS

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

January 23, 2026
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market

January 23, 2026
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System

January 15, 2026
BD Names Shawn Bevec as Senior Vice President of Investor Relations

January 14, 2026
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs

January 13, 2026
BD To Host Virtual 2026 Annual Meeting of Shareholders

January 12, 2026
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial

January 5, 2026
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec

December 22, 2025
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry

December 18, 2025
BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results

November 11, 2025